Preparation and characterization of lipid based nanosystems for topical delivery of quercetin

European Journal of Pharmaceutical Sciences

Volumn 48, Issue 3, 2013, Pages 442-452

  Bose, Sonali ^a,b   Michniak Kohn, Bozena ^a  

^a RUTGERS UNIVERSITY   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Nanostructured lipid carriers; Oleic acid; Physical stability; Solid lipid; Solid lipid nanoparticles; Sonication

Indexed keywords

FLAVONOID; LIPID; NANOMATERIAL; NANOSTRUCTURED LIPID CARRIER; QUERCETIN; SOLID LIPID NANOPARTICLE; SOLVENT; UNCLASSIFIED DRUG; ANTIOXIDANT; DERMATOLOGICAL AGENT; DOCUSATE SODIUM; EXCIPIENT; FATTY ACID; GLYCEROL BEHENATE; OLEIC ACID; POLYSORBATE; SURFACTANT;

ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG STABILITY; FREEZE DRYING; HUMAN; NANOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; THICKNESS; ZETA POTENTIAL; CHEMISTRY; COMPARATIVE STUDY; FEASIBILITY STUDY; IN VITRO STUDY; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; PERMEABILITY; PROCEDURES; SKIN; SKIN ABSORPTION; TOPICAL DRUG ADMINISTRATION; ULTRASOUND;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, TOPICAL; ANTIOXIDANTS; DERMATOLOGIC AGENTS; DIOCTYL SULFOSUCCINIC ACID; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EXCIPIENTS; FATTY ACIDS; FEASIBILITY STUDIES; HUMANS; IN VITRO TECHNIQUES; NANOSTRUCTURES; NANOTECHNOLOGY; OLEIC ACID; PERMEABILITY; POLYSORBATES; QUERCETIN; SKIN; SKIN ABSORPTION; SURFACE-ACTIVE AGENTS; ULTRASONICS;

EID: 84872424706     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2012.12.005     Document Type: Article

References (64)

1. Araujo, J., Gonzalez-Mira, E., Egea, M.A., Garcia, M.L., Souto, E.B., 2010. Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications. Int. J. Pharm. 393, 168-176.
2. Bors, W., Heller, W., Michel, C., Saran, M., 1990. Flavonoids as antioxidants: Determination of radical-scavenging efficiencies. Methods Enzymol. 186, 343-355.
3. Casagrande, R., Georgetti, S.R., Verri Jr., W.A., Dorta, D.J., dos Santos, A.C., Fonseca, M.J., 2006. Protective effect of topical formulations containing quercetin against UVB-induced oxidative stress in hairless mice. J. Photochem. Photobiol. B 84, 21-27.
4. Chapman, D., 1962. The polymorphism of glycerides. Chem. Rev. 62, 433-456.
5. Chen-yu, G., Chun-fen, Y., Qi-lu, L., Qi, T., Yan-wei, X., Wei-na, L., Guang-xi, Z., 2012. Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery. Int. J. Pharm. 430, 292-298.
6. Cirri, M., Bragagni, M., Mennini, N., Mura, P., 2012. Development of a new delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for ketoprofen topical delivery. Eur. J. Pharm. Biopharm. 80, 46-53.
7. Das, S., Ng, W.K., Kanaujia, P., Kim, S., Tan, R.B., 2011. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: Effects of process variables. Colloids Surf. B Biointerfaces 88, 483-489.
8. El Maghraby, G.M., Williams, A.C., Barry, B.W., 2004. Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. Int. J. Pharm. 276, 143-161.
9. Epstein, J.H., 1983. Phototoxicity and photoallergy in man. J. Am. Acad. Dermatol. 8, 141-147.
10. Esposito, E., Fantin, M., Marti, M., Drechsler, M., Paccamiccio, L., Mariani, P., Sivieri, E., Lain, F., Menegatti, E., Morari, M., Cortesi, R., 2008. Solid lipid nanoparticles as delivery systems for bromocriptine. Pharm. Res. 25, 1521-1530.
11. Fang, J.Y., Hwang, T.L., Fang, C.L., Chiu, H.C., 2003. In vitro and in vivo evaluations of the efficacy and safety of skin permeation enhancers using flurbiprofen as a model drug. Int. J. Pharm. 255, 153-166.
12. Filipe, P., Silva, J.N., Haigle, J., Freitas, J.P., Fernandes, A., Santus, R., Morliere, P., 2005. Contrasting action of flavonoids on phototoxic effects induced in human skin fibroblasts by UVA alone or UVA plus cyamemazine, a phototoxic neuroleptic. Photochem. Photobiol. Sci. 4, 420-428.
13. Francoeur, M.L., Golden, G.M., Potts, R.O., 1990. Oleic acid: Its effects on stratum corneum in relation to (trans)dermal drug delivery. Pharm. Res. 7, 621-627.
14. Freitas, C., Müller, R.H., 1998. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN) dispersions. Int. J. Pharm. 168, 221-229.
15. Freitas, C., Müller, R.H., 1999. Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase. Eur. J. Pharm. Biopharm. 47, 125-132.
16. Golden, G.M., McKie, J.E., Potts, R.O., 1987. Role of stratum corneum lipid fluidity in transdermal drug flux. J. Pharm. Sci. 76, 25-28.
17. Gonzalez, S., Fernandez-Lorente, M., Gilaberte-Calzada, Y., 2008. The latest on skin photoprotection. Clin. Dermatol. 26, 614-626.
18. Gonzalez-Mira, E., Nikolic, S., Garcia, M.L., Egea, M.A., Souto, E.B., Calpena, A.C., 2011. Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen. J. Pharm. Sci. 100, 242-251.
19. Goodman, M., Barry, B.W., 1989. Lipid-protein-partitioning (LPP) theory of skin enhancer activity: Finite dose technique. Int. J. Pharm. 57, 29-40.
20. Grabnar, P.A., Kristl, J., 2011. The manufacturing techniques of drug-loaded polymeric nanoparticles from preformed polymers. J. Microencapsul. 28, 323-335.
21. Gugler, R., Leschik, M., Dengler, H.J., 1975. Disposition of quercetin in man after single oral and intravenous doses. Eur. J. Clin. Pharm. 9, 229-234.
22. Hamdani, J., Moes, A.J., Amighi, K., 2003. Physical and thermal characterisation of precirol and compritol as lipophilic glycerides used for the preparation of controlled-release matrix pellets. Int. J. Pharm. 260, 47-57.
23. Hu, F.Q., Jiang, S.P., Du, Y.Z., Yuan, H., Ye, Y.Q., Zeng, S., 2005. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf. B Biointerfaces 45, 167-173.
24. Jenning, V., Gysler, A., Schafer-Korting, M., Gohla, S.H., 2000a. Vitamin A loaded solid lipid nanoparticles for topical use: Occlusive properties and drug targeting to the upper skin. Eur. J. Pharm. Biopharm. 49, 211-218.
25. Jenning, V., Schafer-Korting, M., Gohla, S., 2000b. Vitamin A-loaded solid lipid nanoparticles for topical use: Drug release properties. J. Control. Release 66, 115-126.
26. Jenning, V., Thunemann, A.F., Gohla, S.H., 2000c. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int. J. Pharm. 199, 167-177.
27. Jensen, L.B., Petersson, K., Nielsen, H.M., 2011. In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin. Eur. J. Pharm. Biopharm. 79, 68-75.
28. Jores, K., Mehnert, W., Drechsler, M., Bunjes, H., Johann, C., Mader, K., 2004. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J. Control. Release 95, 217-227.
29. Kitagawa, S., Tanaka, Y., Tanaka, M., Endo, K., Yoshii, A., 2009. Enhanced skin delivery of quercetin by microemulsion. J. Pharm. Pharmacol. 61, 855-860.
30. Kuo, Y.C., Chung, J.F., 2011. Physicochemical properties of nevirapine-loaded solid lipid nanoparticles and nanostructured lipid carriers. Colloids Surf. B Biointerfaces 83, 299-306.
31. Li, H., Zhao, X., Ma, Y., Zhai, G., Li, L., Lou, H., 2009. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J. Control Release 133, 238-244.
32. Lombardi Borgia, S., Regehly, M., Sivaramakrishnan, R., Mehnert, W., Korting, H.C., Danker, K., Roder, B., Kramer, K.D., Schafer-Korting, M., 2005. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J. Control. Release 110, 151-163.
33. Luo, Q., Zhao, J., Zhang, X., Pan, W., 2011. Nanostructured lipid carrier (NLC) coated with chitosan oligosaccharides and its potential use in ocular drug delivery system. Int. J. Pharm. 403, 185-191.
34. Maia, C.S., Mehnert, W., Schafer-Korting, M., 2000. Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int. J. Pharm. 196, 165-167.
35. Mitri, K., Shegokar, R., Gohla, S., Anselmi, C., Muller, R.H., 2011. Lipid nanocarriers for dermal delivery of lutein: Preparation, characterization, stability and performance. Int. J. Pharm. 414, 267-275.
36. Montenegro, L., Carbone, C., Maniscalco, C., Lambusta, D., Nicolosi, G., Ventura, C.A., Puglisi, G., 2007. In vitro evaluation of quercetin-3-O-acyl esters as topical prodrugs. Int. J. Pharm. 336, 257-262.
37. Moreira, T.S., de Sousa, V.P., Pierre, M.B., 2010. A novel transdermal delivery system for the anti-inflammatory lumiracoxib: Influence of oleic acid on in vitro percutaneous absorption and in vivo potential cutaneous irritation. AAPS. Pharm. Sci. Technol. 11, 621-629.
38. Muller, R.H., Radtke, M., Wissing, S.A., 2002. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 54 (Suppl 1), S131-S155.
39. Muller, R.H., Petersen, R.D., Hommoss, A., Pardeike, J., 2007. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv. Drug Deliv. Rev. 59, 522-530.
40. Murakami, T., Yoshioka, M., Yumoto, R., Higashi, Y., Shigeki, S., Ikuta, Y., Yata, N., 1998. Topical delivery of keloid therapeutic drug, tranilast, by combined use of oleic acid and propylene glycol as a penetration enhancer: Evaluation by skin microdialysis in rats. J. Pharm. Pharmacol. 50, 49-54.
41. Olivella, M.S., Lhez, L., Pappano, N.B., Debattista, N.B., 2007. Effects of dimethylformamide and L-menthol permeation enhancers on transdermal delivery of quercetin. Pharm. Dev. Technol. 12, 481-484.
42. Ongpipattanakul, B., Burnette, R.R., Potts, R.O., Francoeur, M.L., 1991. Evidence that oleic acid exists in a separate phase within stratum corneum lipids. Pharm. Res. 8, 350-354.
43. Pardeike, J., Weber, S., Haber, T., Wagner, J., Zarfl, H.P., Plank, H., Zimmer, A., 2011. Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application. Int. J. Pharm. 419, 329-338.
44. Pourzand, C., Tyrrell, R.M., 1999. Apoptosis, the role of oxidative stress and the example of solar UV radiation. Photochem. Photobiol. 70, 380-390.
45. Saija, A., Scalese, M., Lanza, M., Marzullo, D., Bonina, F., Castelli, F., 1995. Flavonoids as antioxidant agents: Importance of their interaction with biomembranes. Free Radical Biol. Med. 19, 481-486.
46. Schafer-Korting, M., Mehnert, W., Korting, H.C., 2007. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv. Drug Deliv. Rev. 59, 427-443.
47. Siekmann, B., Westesen, K., 1994. Melt-homogenized solid lipid nanoparticles stabilized by the nonionic surfactant tyloxapol. I. Preparation and particle size determination. Pharm. Pharmacol. Lett. 3, 194-197.
48. Silva, A.C., Santos, D., Ferreira, D.C., Souto, E.B., 2009. Minoxidil-loaded nanostructured lipid carriers (NLC): Characterization and rheological behaviour of topical formulations. Pharmazie 64, 177-182.
49. Sim, G.S., Lee, B.C., Cho, H.S., Lee, J.W., Kim, J.H., Lee, D.H., Kim, J.H., Pyo, H.B., Moon, D.C., Oh, K.W., Yun, Y.P., Hong, J.T., 2007. Structure activity relationship of antioxidative property of flavonoids and inhibitory effect on matrix metalloproteinase activity in UVA-irradiated human dermal fibroblast. Arch. Pharm. Res. 30, 290-298.
50. Sintov, A., Ze'evi, A., Uzan, R., Nyska, A., 1999. Influence of pharmaceutical gel vehicles containing oleic acid/sodium oleate combinations on hairless mouse skin, a histological evaluation. Eur. J. Pharm. Biopharm. 47, 299-303.
51. Song, C.K., Balakrishnan, P., Shim, C.K., Chung, S.J., Chong, S., Kim, D.D., 2012. A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: Characterization and in vitro/in vivo evaluation. Colloids Surf. B Biointerfaces 92, 299-304.
52. Souto, E.B., Wissing, S.A., Barbosa, C.M., Muller, R.H., 2004. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int. J. Pharm. 278, 71-77.
53. Tan, Q., Liu, W., Guo, C., Zhai, G., 2011. Preparation and evaluation of quercetinloaded lecithin-chitosan nanoparticles for topical delivery. Int. J. Nanomedicine. 6, 1621-1630.
54. Tanojo, H., Boelsma, E., Junginger, H.E., Ponec, M., Boddec, H.E., 1999. In vivo human skin permeability enhancement by oleic acid: A laser doppler velocimetry study. J. Control Release 58, 97-104.
55. Teeranachaideekul, V., Souto, E.B., Junyaprasert, V.B., Muller, R.H., 2007. Cetyl palmitate-based NLC for topical delivery of coenzyme Q(10)-development, physicochemical characterization and in vitro release studies. Eur. J. Pharm. Biopharm. 67, 141-148.
56. Teeranachaideekul, V., Boonme, P., Souto, E.B., Muller, R.H., Junyaprasert, V.B., 2008. Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC. J. Control. Release 128, 134-141.
57. Tiwari, R., Pathak, K., 2011. Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: Comparative analysis of characteristics, pharmacokinetics and tissue uptake. Int. J. Pharm. 415, 232-243.
58. Touitou, E., Godin, B., Karl, Y., Bujanover, S., Becker, Y., 2002. Oleic acid, a skin penetration enhancer, affects langerhans cells and corneocytes. J. Control. Release 80, 1-7.
59. Vicentini, F.T., Simi, T.R., Del Ciampo, J.O., Wolga, N.O., Pitol, D.L., Iyomasa, M.M., Bentley, M.V., Fonseca, M.J., 2008. Quercetin in w/o microemulsion: In vitro and in vivo skin penetration and efficacy against UVB-induced skin damages evaluated in vivo. Eur. J. Pharm. Biopharm. 69, 948-957.
60. Yamane, M.A., Williams, A.C., Barry, B.W., 1995. Effects of terpenes and oleic acid as skin penetration enhancers towards 5-fluorouracil as assessed with time; permeation, partitioning and differential scanning calorimetry. Int. J. Pharm. 116, 237-251.
61. Ying, X.Y., Du, Y.Z., Chen, W.W., Yuan, H., Hu, F.Q., 2008. Preparation and characterization of modified lipid nanoparticles for doxorubicin controlled release. Pharmazie 63, 878-882.
62. You, J., Wan, F., de, C.F., Sun, Y., Du, Y.Z., Hu, F.Q., 2007. Preparation and characteristic of vinorelbine bitartrate-loaded solid lipid nanoparticles. Int. J. Pharm. 343, 270-276.
63. Yu, A., Guo, C., Zhou, Y., Cao, F., Zhu, W., Sun, M., Zhai, G., 2010. Skin irritation and the inhibition effect on HSV-1 in vivo of penciclovir-loaded microemulsion. Int. Immunopharmacol. 10, 1305-1309.
64. Zhang, J., Smith, E., 2011. Percutaneous permeation of betamethasone 17-valerate incorporated in lipid nanoparticles. J. Pharm. Sci. 100, 896-903.